The U.S-China electron gap may slow progress at OpenAI and others, buying time for firms in the People's Republic to catch up in chips. But it may also set the stage for another boom-and-bust cycle ...
Shares of Cipla declined 4% on January 7 after the US Food and Drug Administration (FDA) disclosed inspection observations ...
U.S. flu infections surged over the holidays, and health officials are calling it a severe season that is likely to get worse ...
Industry sources tells told Moneycontrol that delivery partners earned about Rs 150 crore through tips in 2025, which was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback